Author

Casper Rokx

Erasmus MCORCID 0000-0002-1904-6450Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Approach:experimental assay· 4 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Assay:DNA methylation· 1

Frequent Co-Authors

Tokameh MahmoudiiD· 4 shared Raquel CrespoiD· 3 shared Robert-Jan T. S. PalstraiD· 3 shared Alicja Górska· 2 shared Cynthia LunguiD· 2 shared David A. M. C. van de VijveriD· 2 shared Enrico NeiD· 2 shared Peter D. KatsikisiD· 2 shared

Activity by Year

2020-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

Tokameh MahmoudiORCID

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

ImmunologybioRxivPreprintAug 26, 2026

Larger inducible reservoir and higher abundance of exhausted CD8+ T cells in people treated after late versus non-late diagnosis of chronic HIV one year after ART initiation

Kathryn S. Hensley, Liset de Vries, Tanvir Hossain…·Tokameh Mahmoudi

DOI 10.64898/2026.03.31.715509

humanflow cytometry

𝕏 PostBluesky

ImmunologybioRxivPreprintApr 6, 2026

Viral persistence and antiretroviral therapy shape systemic immune aging in treated HIV infection

Yubo Zhang, Vasiliki Matzaraki, Adriana Navas…·Mihai Gheorghe Netea

This study shows that HIV persistence accelerates immune aging in treated individuals, while certain antiretroviral drugs reduce it.

DOI 10.64898/2026.04.01.715809

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintFeb 24, 2025

HIV-specific CD8+ T-cell proliferative response 24 weeks after early antiretroviral therapy initiation predicts the subsequent reduction of the viral reservoir

Pien M van Paassen, Alexander O. Pasternak, Dita C. Bolluyt…·Godelieve J. de Bree

2 citations

humanexperimental assay

𝕏 PostBluesky

Molecular BiologyNucleic Acids ResearchPeer-reviewedMay 30, 2022

Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents

Enrico Ne, Raquel Crespo, Ray W. Izquierdo-Lara…·Tokameh Mahmoudi

Catchet-MS identifies thalidomide analogues targeting IKZF1 as novel HIV-1 latency reversal agents by reversing latency in CD4+ T-cells.

15 citations

humanproteomics

𝕏 PostBluesky

Molecular BiologyScience AdvancesPeer-reviewedAug 12, 2020

Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb and reverses HIV-1 latency

Mateusz Stoszko, Abdullah M. S. Al‐Hatmi, Anton Škríba…·Tokameh Mahmoudi

The paper identifies gliotoxin as a novel LRA that disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency in CD4+ T cells.

26 citations

humanbulk RNA-seq

𝕏 PostBluesky